Adhesion Molecule with Ig-Like Domain 2 (AMIGO2) (Middle Region) Peptide
AMIGO2
Reactivity: Rat
Host: Synthetic
BP, WB
-
- Target See all AMIGO2 products
- AMIGO2 (Adhesion Molecule with Ig-Like Domain 2 (AMIGO2))
- Protein Region
- Middle Region
- Origin
- Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- FHALGFIHEA QVGERAIVHC DGKTGNGNTD FIWVGPDNRL LEPDKDTGNF
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Amigo2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- AMIGO2 (Adhesion Molecule with Ig-Like Domain 2 (AMIGO2))
- Background
-
Amigo2 is required for depolarization-dependent survival of cultured cerebellar granule neurons. It may mediate homophilic as well as heterophilic cell-cell interaction with AMIGO1 or AMIGO3. It also may contribute to signal transduction through its intracellular domain.
Alias Symbols: Ali1, Amigo2
Protein Size: 520 - Molecular Weight
- 57 kDa
- Gene ID
- 300186
- NCBI Accession
- NM_182816, NP_877968
- UniProt
- Q7TNJ4
-
You are here:
